Working with Regeneron and Sanofi, Express Scripts directly delivers drug-specific savings to patients, making PCSK9 therapy more affordable and more accessible.
Accredo's holistic rare disease patient care yields a 27% increase in medication adherence.
Express Scripts is working to control costs with high-touch clinical care for the more than 30 million people in the U.S. living with diabetes.
Our study, presented at the NORD Rare Summit, shows the positive impact interventions can have on medication adherence for people with rare disease.
February is American Heart Month. Take a few moments to learn more - for your heart’s sake.